Drug
Foralumab
Foralumab: highest development phase Phase 2, developed by Tiziana Life Sciences LTD. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Tiziana Life Sciences LTD
Trials
| Drug | Phase | Indication |
|---|---|---|
| Foralumab NCT06292923 | Phase 2 | Secondary Progressive Multiple Sclerosis |
Latest
No recent events.
Follow Foralumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.